Treating cancer with fewer toxic side effects

Health Report - Separate stories podcast

Hodgkin lymphoma is a cancer that typically affects young adults.

Because of this, there are many things to consider before treatment starts – not just how effective it will be, but its long-term impacts.

Australian researchers have been part of a clinical trial to find effective first-line treatments for the disease that prevent toxic side effects.

Guest

• Professor Mark Hertzberg, clinical haematology at Prince of Wales Hospital and UNSW

References

• Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21)